Screener / SEC EDGAR /CIK 0001107843 /10-K filed Feb 20, 2026, compared with Feb 21, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Software

Qualys, Inc. QLYS

Compare with peers Embed
Planned sales, announced before they happen

7 trading plans running, 23 Form 144 notices for $23.0M

10-Q, 10-K and Form 144
Plans running now 7 Jeffrey P. Hank, Bruce Posey, Joo Mi Kim, Sumedh S. Thakar, Thomas P. Berquist, Wendy M. Pfeiffer
Plans adopted 20 reported since May 4, 2023 Form 144 notices 23 $23.0M the sellers expected to sell

What QLYS's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Feb 26, 2025 to Nov 1, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Jeffrey P. Hank
chair of our board of directors
Adopted 10b5-1 plan Aug 26, 2026 10-Q Nov 9, 2026
What the company wrote
On August 26, 2026, Jeffrey P. Hank, the chair of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 4,314 shares of our common stock, consisting of (i) 3,000 shares of our common stock currently held by Mr. Hank and (ii) 1,314 shares of our common stock issuable upon the vesting and settlement of RSUs. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until August 31, 2027, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in August 2026, Mr. Hank's previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Bruce Posey
Chief Legal Officer
Adopted 10b5-1 plan Aug 21, 2026 10-Q Nov 9, 2026
What the company wrote
On August 21, 2026, Bruce Posey, our Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 25,183 shares of our common stock, consisting of (i) 10,300 shares of our common stock currently held by Mr. Posey and (ii) 14,883 shares of our common stock issuable upon the vesting and settlement of RSUs and PRSUs, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 1, 2027, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in August 2026, Mr. Posey's previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Joo Mi Kim
Chief Financial Officer
Adopted 10b5-1 plan Aug 10, 2026 10-Q Nov 9, 2026
What the company wrote
On August 10, 2026, Joo Mi Kim, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 28,280 shares of our common stock, consisting of (i) 17,235 shares of our common stock currently held by Ms. Kim and (ii) 11,045 shares of our common stock issuable upon the vesting and settlement of PRSUs, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until August 31, 2027, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in August 2026, Ms. Kim’s previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Sumedh S. Thakar
Chief Executive Officer and a member of our board of directors
Adopted 10b5-1 plan Feb 27, 2026 10-Q May 5, 2026
What the company wrote
On February 27, 2026, Sumedh S. Thakar, our Chief Executive Officer and a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 98,400 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the Company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until April 30, 2027, or earlier if all transactions under the trading arrangement are completed. This trading arrangement will not commence until the termination of his previous trading arrangement by its terms on April 30, 2026.
Thomas P. Berquist
member of our board of directors
Adopted 10b5-1 plan Feb 27, 2026 10-Q May 5, 2026
What the company wrote
On February 27, 2026, Thomas P. Berquist, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 1,450 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 27, 2027, or earlier if all transactions under the trading arrangement are completed.
Jeffrey P. Hank
chair of our board of directors
Adopted 10b5-1 plan Feb 25, 2026 10-Q May 5, 2026
What the company wrote
On February 25, 2026, Jeffrey P. Hank, the chair of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 940 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 28, 2027, or earlier if all transactions under the trading arrangement are completed.
Wendy M. Pfeiffer
member of our board of directors
Adopted 10b5-1 plan Feb 20, 2026 10-Q May 5, 2026
What the company wrote
On February 20, 2026, Wendy M. Pfeiffer, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,000 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 23, 2027, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in February 2026, Ms. Pfeiffer's previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Bruce Posey
Chief Legal Officer
Adopted 10b5-1 plan Aug 21, 2025 10-Q Nov 4, 2025
What the company wrote
On August 21, 2025, Bruce Posey, our Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 22,234 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 1, 2026, or earlier if all transactions under the trading arrangement are completed.
Joo Mi Kim
Chief Financial Officer
Adopted 10b5-1 plan Aug 12, 2025 10-Q Nov 4, 2025
What the company wrote
On August 12, 2025, Joo Mi Kim, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 51,509 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 10, 2026, or earlier if all transactions under the trading arrangement are completed.
Sumedh S. Thakar
Chief Executive Officer and a member of our board of directors
Adopted 10b5-1 plan Feb 26, 2025 10-Q May 6, 2025
What the company wrote
On February 26, 2025, Sumedh S. Thakar, our Chief Executive Officer and a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 118,000 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the Company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). Mr. Thakar's new Rule 10b5-1 trading arrangement will not commence until his previous Rule 10b5-1 trading arrangement terminates by its terms. The duration of the trading arrangement is until April 30, 2026, or earlier if all transactions under the trading arrangement are completed.
Wendy M. Pfeiffer
member of our board of directors
Adopted 10b5-1 plan Feb 21, 2025 10-Q May 6, 2025
What the company wrote
On February 21, 2025, Wendy M. Pfeiffer, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 600 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 21, 2026, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in February 2025, Ms. Pfeiffer's previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Thomas P. Berquist
member of our board of directors
Adopted 10b5-1 plan Feb 19, 2025 10-Q May 6, 2025
What the company wrote
On February 19, 2025, Thomas P. Berquist, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 1,168 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until February 19, 2026, or earlier if all transactions under the trading arrangement are completed.
Bruce Posey
Chief Legal Officer
Adopted 10b5-1 plan Aug 21, 2024 10-Q Nov 5, 2024
What the company wrote
On August 21, 2024, Bruce Posey, our Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 54,586 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until December 2, 2025, or earlier if all transactions under the trading arrangement are completed.
Joo Mi Kim
Chief Financial Officer
Adopted 10b5-1 plan Aug 21, 2024 10-Q Nov 5, 2024
What the company wrote
On August 21, 2024, Joo Mi Kim, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 54,319 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 20, 2025, or earlier if all transactions under the trading arrangement are completed.
Jeffrey P. Hank
chair of our board of directors
Ended 10b5-1 plan Aug 16, 2024 10-Q Nov 5, 2024
What the company wrote
On August 16, 2024, Jeffrey P. Hank, the chair of our board of directors, modified his existing Rule 10b5-1 trading arrangement dated November 21, 2023 (the “Original Plan”), which has the effect of terminating the Original Plan and adopting a new Rule 10b5-1 trading arrangement (the “New Plan”). The New Plan provides for the sale from time to time of an aggregate of up to 8,850 shares of our common stock plus an additional number of shares to be acquired on the date of the Company's 2025 Annual Meeting of Stockholders. Pursuant to the Company's non-employee director compensation program, each non-employee director who has served on our board of directors for at least six months prior to such date will be granted an annual award of restricted stock units on such day. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the New Plan is until June 30, 2025, or earlier if all transactions under the trading arrangement are completed.
Sumedh S. Thakar
Chief Executive Officer
Adopted 10b5-1 plan Feb 28, 2024 10-Q May 7, 2024
What the company wrote
On February 28, 2024, Sumedh S. Thakar, our Chief Executive Officer and a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 114,000 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 28, 2025, or earlier if all transactions under the trading arrangement are completed.
Wendy M. Pfeiffer
board of directors
Adopted 10b5-1 plan Feb 23, 2024 10-Q May 7, 2024
What the company wrote
On February 23, 2024, Wendy M. Pfeiffer, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 2,000 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until May 23, 2025, or earlier if all transactions under the trading arrangement are completed. Prior to entering into the new Rule 10b5-1 trading arrangement in February 2024, Ms. Pfeiffer’s previous Rule 10b5-1 trading arrangement expired according to its terms because all the transactions under the arrangement were completed.
Jeffrey P. Hank
chair of our board of directors
Adopted 10b5-1 plan Nov 21, 2023 10-K Feb 22, 2024
What the company wrote
During the three months ended December 31, 2023, the following director, as defined in Rule 16a-1(f), adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408, as follows: On November 21, 2023, Jeffrey P. Hank, the chair of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 8,850 shares of our common stock plus an additional number of shares to be granted on the date of the Company's 2024 Annual Meeting of Stockholders. Pursuant to the Company's non-employee director compensation program, each non-employee director who has served on our board of directors for at least six months prior to such date will be granted an award of restricted stock units with an intended value (based on the average of the closing prices of our common stock for the 30 trading days ending one week before the applicable grant date) of $200,000. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until June 30, 2025, or earlier if all transactions under the trading arrangement are completed.
Wendy Pfeiffer
board of directors
Adopted 10b5-1 plan Aug 31, 2023 10-Q Nov 2, 2023
What the company wrote
On August 31, 2023, Wendy Pfeiffer, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 6,640 shares of our common stock. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until September 3, 2024, or earlier if all transactions under the trading arrangement are completed.
Bruce Posey
Chief Legal Officer
Adopted 10b5-1 plan Aug 28, 2023 10-Q Nov 2, 2023
What the company wrote
On August 28, 2023, Bruce Posey, our Chief Legal Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 25,381 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 29, 2024, or earlier if all transactions under the trading arrangement are completed.
Joo Mi Kim
Chief Financial Officer
Adopted 10b5-1 plan Aug 28, 2023 10-Q Nov 2, 2023
What the company wrote
On August 28, 2023, Joo Mi Kim, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of up to 31,606 shares of our common stock, which represents the gross number of shares authorized to be sold during the duration of the plan, before excluding any shares withheld by the company to satisfy its income tax withholding in connection with the net settlement of the equity awards. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until November 29, 2024, or earlier if all transactions under the trading arrangement are completed.
Show the other 13 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 2, 2026 JOO MI KIM
Officer
2,659 $596K
Oct 14, 2026 SUMEDH THAKAR
Director, Officer
9,600 $1.9M
Aug 20, 2026 BRUCE POSEY
Officer
2,613 $488K
Aug 3, 2026 JOO MI KIM
Officer
2,657 $385K
Jul 20, 2026 BRUCE POSEY
Officer
354 $56K
Jul 2, 2026 JOO MI KIM
Officer
965 $138K
Jun 30, 2026 SUMEDH THAKAR
Director, Officer
30,000 $3.8M
Jun 29, 2026 SUMEDH THAKAR
Director, Officer
10,000 $1.2M
Jun 26, 2026 SUMEDH THAKAR
Director, Officer
13,200 $1.5M
Jun 12, 2026 THOMAS BERQUIST
Director
1,450 $161K
Jun 11, 2026 JEFFREY HANK
Director
940 $104K
Jun 2, 2026 JOO MI KIM
Officer
1,031 $118K
Jun 1, 2026 SUMEDH THAKAR
Director, Officer
22,800 $2.5M
May 22, 2026 WENDY M. PFEIFFER
Director
2,000 $202K
May 19, 2026 JOO MI KIM
Officer
1,627 $159K
May 19, 2026 BRUCE POSEY
Officer
5,642 $553K
Feb 4, 2026 JOO MI KIM
Officer
6,799 $867K
Feb 2, 2026 JOO MI KIM
Officer
3,414 $450K
Jan 20, 2026 BRUCE POSEY
Officer
1,801 $242K
Dec 15, 2025 SUMEDH THAKAR
Director, Officer
17,200 $2.6M
Dec 3, 2025 BRUCE K. POSEY
Officer
5,605 $817K
Dec 2, 2025 JOO MI KIM
Officer
20,908 $3.0M
Nov 21, 2025 JOO MI KIM
Officer
7,694 $1.1M
Show the other 15 notices

From the Form 144 XML filed with the SEC, since Nov 21, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/QLYS/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.